Body Pro 2
Body composition cellular scale
Segmental body composition
Body Pro 3 shows care teams where fat and muscle change, segment by segment.
“As a nurse, I want to see more than a single number. This is the most accurate body composition results I’ve seen from a home scale, and the zone-by-zone breakdown shows whether a care plan is working well or needs adjustment.”
Tobias Olsson, Clinic Support Manager and Registered Nurse, Yazen
Hypertension notification*
01
No hypertension diagnosis.
02
Joins your weight management program.
03
Body Pro 3 at home, coach, weight loss therapy.
04
Identify patterns suggestive of hypertension & notifies care team.
05
Care teams seek further clinical evaluation.
Program trajectory prediction
Body Pro 3 projects weight, fat and muscle up to 12 months ahead, and refines the forecast at every weigh-in.
Prediction Trajectory
Where each patient is heading, refreshed at every weigh-in.
Goal Probability Score
The chances of reaching the target weight by the target date.
Off-Track Alert
Plateaus and regain spotted early, so care teams can step in.
With cellular connectivity, in addition to Wi-Fi and Bluetooth, you can be sure that the data you need to improve the health of your patients will be accurately collected for all populations.
Our fallback option, the Connect Assistant app, enables Wi-Fi and Bluetooth connectivity for users who don’t have access to reliable cellular networks.
Continuously, securely and seamlessly, the data is transferred via your selected data connection option into our cloud, so you can access the data from your interface of choice.
How it fits your workflow
Body Pro 3 measures weight and delivers segmental body composition: fat mass and muscle mass for each zone of the body, so care teams see where changes happen. It also tracks whole-body indicators, including visceral fat, heart age, vascular age and heart rate. Combined with hypertension notification*, these measurements give care teams a richer view at every weigh-in, without adding a device to the program.
Segmental body composition breaks down fat mass and muscle mass by body zone: arms, legs and trunk. Body Pro 3 delivers these results with bioimpedance spectroscopy across 13 frequencies up to 800 kHz and 8 electrodes. For care teams, it answers a question the scale number alone cannot: is weight loss coming from fat or from muscle? This is especially relevant for patients on GLP-1 treatment, where preserving lean mass is a key part of the care plan.
Hypertension notification analyzes weigh-in data to identify patterns suggestive of hypertension and notifies the user to seek further clinical evaluation. It does not measure blood pressure and does not replace a blood pressure measurement.*
Program Trajectory Prediction projects each patient's weight trajectory from their measurement history. It combines three components: Prediction Trajectory shows where a patient is heading, Goal Probability Score estimates their likelihood of reaching their goal, and Off-Track Alert notifies care teams when progress drifts. Care teams can focus their time on the patients who need support most, before disengagement sets in.
Body Pro 3 is not FDA cleared.
Body Pro 3 supports cellular connectivity, ensuring reliable data transmission across all patient populations. For patients without access to stable cellular networks, the Connect Assistant app provides a Wi-Fi and Bluetooth fallback. All data is transferred securely to the Withings cloud and can be accessed through your platform of choice, integrating smoothly into existing care workflows.
Body Pro 3 can be shipped directly to your patients after an API call. Data flows to our HIPAA compliant cloud and is available via API, or through Withings RPM, our remote monitoring platform. Our team supports you from technical integration to logistics, so your program can scale without added operational load.
References
1. 2025 study with Mon Stade, a health and sports center authorized by the French regional health authority, 80 participants compared against a DEXA control scan.
2. Withings Health Solutions, Inside the GLP-1 Patient Journey, Research Report, 2026. Projections are statistical estimates, not clinical guarantees.
*Pending FDA 510(k) clearance. Not available for sale in the United States. The Hypertension Notification Feature is intended to notify adults 22 and older who have not been previously diagnosed with hypertension to seek further clinical evaluation. It is not for use in pregnancy and is not a standalone diagnostic tool or a blood pressure surveillance method.